Call for Papers
Perinatal Diagnostics and Risk Prediction: Current Practice and Future Directions
Submit now
Clinical Chemistry is pleased to announce an upcoming special issue “Perinatal Diagnostics and Risk Prediction: Current Practice and Future Directions,” edited by Drs. Robert D. Nerenz, A.J. Agopian, Philip J. Lupo, Khushbu Patel, and Nandini Raghuraman. Clinical Chemistry, published by the Association for Diagnostics & Laboratory Medicine and Oxford University Press, is the most highly cited forum for peer reviewed, original research in the field of clinical laboratory medicine.
Potential topics of interest include, but are not limited to:
- Infectious disease testing in pregnancy and the neonatal period
- Incorporation of novel biomarkers in prenatal care delivery pathways
- Outcomes studies demonstrating value of biomarker measurement
- Data analytics to improve perinatal health
- Machine learning to predict pregnancy and neonatal outcomes
- Population health studies of early childhood
- Advances in newborn screening
- Clinical genetics and genomics of perinatal health
- New applications of cell-free DNA
- Ethics of genetic testing in pregnancy or newborn period
- Reference intervals for laboratory testing of neonates, infants, or in pregnancy
- Emerging analytical technologies in pregnancy and/or the neonatal period
- Laboratory testing in the setting of pregnancies after uterine transplantation
- Maternal risk factors for pregnancy outcomes with laboratory testing implications
Clinical Chemistry invites authors to submit original articles related to perinatal diagnostics to be considered for publication in this special issue. Journal guidelines for submission apply as described in the Instructions to Authors.
Deadline: June 1, 2025
Submissions must be received at mc.manuscriptcentral.com/clinchem.
Special Issues
Please enjoy our most recent themed issue:
Genomics: Current & Emerging Trends in the Clinical Laboratory
January 2025
Edited by Drs. Tina Lockwood, Heather Mason-Suares, Ann M. Moyer, Pavitra Roychoudhury, and Dave Spencer.
